FR2622108B1 - Preparation de concentres de proconvertine (facteur vii), de facteur antihemophilique b (facteur ix) et d'autres proteines plasmatiques, et leur utilisation therapeutique - Google Patents

Preparation de concentres de proconvertine (facteur vii), de facteur antihemophilique b (facteur ix) et d'autres proteines plasmatiques, et leur utilisation therapeutique

Info

Publication number
FR2622108B1
FR2622108B1 FR8714665A FR8714665A FR2622108B1 FR 2622108 B1 FR2622108 B1 FR 2622108B1 FR 8714665 A FR8714665 A FR 8714665A FR 8714665 A FR8714665 A FR 8714665A FR 2622108 B1 FR2622108 B1 FR 2622108B1
Authority
FR
France
Prior art keywords
factor
proconvertine
concentrates
preparation
therapeutic use
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR8714665A
Other languages
English (en)
French (fr)
Other versions
FR2622108A1 (fr
Inventor
Catherine Michalski
Thierry Burnouf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LILLE TRANSFUSION SANGUINE
Original Assignee
LILLE TRANSFUSION SANGUINE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LILLE TRANSFUSION SANGUINE filed Critical LILLE TRANSFUSION SANGUINE
Priority to FR8714665A priority Critical patent/FR2622108B1/fr
Priority to DE3877529T priority patent/DE3877529T2/de
Priority to AT88402643T priority patent/ATE84543T1/de
Priority to EP88402643A priority patent/EP0317376B2/fr
Priority to ES88402643T priority patent/ES2045167T5/es
Priority to DK198805877A priority patent/DK173859B1/da
Priority to NO884688A priority patent/NO179997C/no
Priority to JP63267004A priority patent/JP2768957B2/ja
Publication of FR2622108A1 publication Critical patent/FR2622108A1/fr
Application granted granted Critical
Publication of FR2622108B1 publication Critical patent/FR2622108B1/fr
Priority to US07/683,109 priority patent/US5457181A/en
Priority to GR930400157T priority patent/GR3006910T3/el
Priority to FR95C0026C priority patent/FR95C0026I2/fr
Priority to GR960401282T priority patent/GR3019900T3/el
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/647—Blood coagulation factors not provided for in a preceding group or according to more than one of the proceeding groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
FR8714665A 1987-10-23 1987-10-23 Preparation de concentres de proconvertine (facteur vii), de facteur antihemophilique b (facteur ix) et d'autres proteines plasmatiques, et leur utilisation therapeutique Expired - Lifetime FR2622108B1 (fr)

Priority Applications (12)

Application Number Priority Date Filing Date Title
FR8714665A FR2622108B1 (fr) 1987-10-23 1987-10-23 Preparation de concentres de proconvertine (facteur vii), de facteur antihemophilique b (facteur ix) et d'autres proteines plasmatiques, et leur utilisation therapeutique
AT88402643T ATE84543T1 (de) 1987-10-23 1988-10-20 Herstellung von hoch-gereingtem menschlichen faktor ix sowie anderem plasmaproteinkonzentrat und dessen therapeutische verwendung.
EP88402643A EP0317376B2 (fr) 1987-10-23 1988-10-20 Préparation de concentré de facteur IX humain de haute pureté et d'autres protéines plasmatiques
ES88402643T ES2045167T5 (es) 1987-10-23 1988-10-20 Preparacion de concentrado de factor ix humano de elevada pureza y de otras proteinas plasmaticas.
DE3877529T DE3877529T2 (de) 1987-10-23 1988-10-20 Herstellung von hoch-gereingtem menschlichen Faktor IX sowie anderem Plasmaproteinkonzentrat und dessen therapeutische Verwendung.
NO884688A NO179997C (no) 1987-10-23 1988-10-21 Fremgangsmåte for fremstilling av terapeutisk anvendbart faktor IX-konsentrat med stor renhet
DK198805877A DK173859B1 (da) 1987-10-23 1988-10-21 Fremgangsmåde til fremstilling af et højrenset humant faktor IX koncentrat og andre plasmaproteiner
JP63267004A JP2768957B2 (ja) 1987-10-23 1988-10-22 高純度のヒト因子ｉｘ濃縮物および他の血漿蛋白質およびそれらの治療学的使用
US07/683,109 US5457181A (en) 1987-10-23 1991-04-11 Preparation of a high-purity human factor IX concentrate and other plasmatic proteins and their therapeutic use
GR930400157T GR3006910T3 (en) 1987-10-23 1993-01-28 Preparation of a concentrate of high-purity human factor IX and of other plasma proteins
FR95C0026C FR95C0026I2 (enExample) 1987-10-23 1995-06-27
GR960401282T GR3019900T3 (en) 1987-10-23 1996-05-13 Preparation of a concentrate of high-purity human factor IX and of other plasma proteins

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8714665A FR2622108B1 (fr) 1987-10-23 1987-10-23 Preparation de concentres de proconvertine (facteur vii), de facteur antihemophilique b (facteur ix) et d'autres proteines plasmatiques, et leur utilisation therapeutique

Publications (2)

Publication Number Publication Date
FR2622108A1 FR2622108A1 (fr) 1989-04-28
FR2622108B1 true FR2622108B1 (fr) 1990-03-02

Family

ID=9356101

Family Applications (2)

Application Number Title Priority Date Filing Date
FR8714665A Expired - Lifetime FR2622108B1 (fr) 1987-10-23 1987-10-23 Preparation de concentres de proconvertine (facteur vii), de facteur antihemophilique b (facteur ix) et d'autres proteines plasmatiques, et leur utilisation therapeutique
FR95C0026C Active FR95C0026I2 (enExample) 1987-10-23 1995-06-27

Family Applications After (1)

Application Number Title Priority Date Filing Date
FR95C0026C Active FR95C0026I2 (enExample) 1987-10-23 1995-06-27

Country Status (1)

Country Link
FR (2) FR2622108B1 (enExample)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE15489T1 (de) * 1980-05-27 1985-09-15 Miles Lab Die blutkoagulation aktivierendes produkt und verfahren zu dessen herstellung.
AT368883B (de) * 1980-07-22 1982-11-25 Immuno Ag Verfahren zur herstellung einer neuen blutgerinnungsfoerdernden praeparation auf basis von humanproteinen

Also Published As

Publication number Publication date
FR95C0026I2 (enExample) 1996-11-08
FR95C0026I1 (enExample) 1996-06-21
FR2622108A1 (fr) 1989-04-28

Similar Documents

Publication Publication Date Title
IL91843A0 (en) Hiv proteins and peptides useful in the diagnosis,prophylaxis aids or therapy of aids
IL76441A0 (en) Blood coagulation inhibiting proteins and their preparation
DK478786D0 (da) Cystein-forarmede muteiner af biologisk aktive humantumornekrosefaktorproteiner
ZA896468B (en) Lyophilization of red blood cells
DE3877529D1 (de) Herstellung von hoch-gereingtem menschlichen faktor ix sowie anderem plasmaproteinkonzentrat und dessen therapeutische verwendung.
FR2579596B1 (fr) (imidazolyl-4) piperidines, leur preparation et leur application en therapeutique
SE8501050D0 (sv) Biologically active fragments of human antihemophilic factor and method for preparation thereof
BE896993A (fr) FACTEURS 1,2,3,4 et 5 DE TEICHOMYCINE A2, LEUR PREPARATION ET LEUR UTILISATION
FR2577557B1 (fr) Peptides et derives peptidiques, leur preparation, leur utilisation en therapeutique et compositions pharmaceutiques les contenant
ZA886273B (en) Novel hiv proteins and peptides useful in the diagnosis,prophylaxis or therapy of aids
ZA881621B (en) Cyclic peptides and their preparation
FR2568774B2 (fr) Medicaments favorisant les proprietes d'ecoulement du sang et leur utilisation en therapeutique
AU8891691A (en) Human proteins having anticoagulant and anti-inflammatory activity
DK141090D0 (da) Fremstilling af human prourokinase
FR2622108B1 (fr) Preparation de concentres de proconvertine (facteur vii), de facteur antihemophilique b (facteur ix) et d'autres proteines plasmatiques, et leur utilisation therapeutique
BE886676A (fr) Pentapeptides homologues d'enkephalines, leur preparation et leur utilisation therapeutique
PT85560A (en) Human low affinity fc epsylon-receptor the isolation the recom-binant preparation and purification thereof
IL91771A0 (en) Increased expression of small molecular weight recombinant proteins
MA19965A1 (fr) 3',5'-diarabinosides, leur preparation et leur application en therapeutique
AU1996388A (en) Proteins and protein compositions and their use
ZA883878B (en) Human immunodeficiency virus gag-encoded proteins
ZA893085B (en) Human immunodeficiency virus(hiv)env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
AU6840487A (en) Plasmid and phage clones of human T-cell lymphotropic virus type III
ZA897509B (en) Novel hiv proteins and peptides useful in the diagnosis,prophylaxis or therapy of aids
NO874320D0 (no) Fremgangsmaate for bestemmelse av funksjonelle nivaaer av protein c i humant plasma.

Legal Events

Date Code Title Description
CP Supplementary protection certificate (spc) filed

Free format text: PRODUCT NAME: FACTEUR IX; NAT. REGISTRATION NO/DATE: NL19762 19941230; FIRST REGISTRATION: FR - NL19762 19941230

Spc suppl protection certif: 95C0026

Filing date: 19950627

CP Supplementary protection certificate (spc) filed

Free format text: 95C0026, 950627

CR Request for supplementary protection certificate laid open to the public (eec regulation of 18 june 1992)

Free format text: 95C0026, 950627

CY Supplementary certificate of protection granted (eec regulation of 18 june 1992)

Free format text: 95C0026, 950627, EXPIRES:20091230

CP Supplementary protection certificate (spc) filed
CA Change of address

Spc suppl protection certif: 95C0026

CD Change of name or company name

Spc suppl protection certif: 95C0026

TP Transmission of property

Spc suppl protection certif: 95C0026